Related Concept Videos
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Position-effect Variegation
Non-LTR Retrotransposons
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Modulation of sirtuin expression by a high-sugar diet and regular swimming trained precedes the loss of kidney function.
The correlation of the fecal microbiome with the biochemical profile during menopause: a Brazilian cohort study.
Nickel, manganese and copper removal by a mixed consortium of sulfate reducing bacteria at a high COD/sulfate ratio.
Related Experiment Video
Updated: Nov 15, 2025

Using Eggs from Schistosoma mansoni as an In vivo Model of Helminth-induced Lung Inflammation
Published on: June 5, 2012
Epigenetic Markers Associated with Schistosomiasis.
R A Gomes Assenço1, E Alves Mota2, V F De Oliveira2,3
1Programa de Pós-Graduação em Ciências Farmacêuticas (CiPharma), Escola de Farmácia, Universidade Federal de Ouro Preto. Ouro Preto, CEP 35400-000, Minas Gerais, Brazil.
Epigenetic biomarkers offer a promising avenue for schistosomiasis diagnosis, overcoming limitations of current methods like microscopy and immunological screening. These molecular approaches aim for earlier disease detection and improved treatment to prevent liver damage.
More Related Videos
Area of Science:
- Medical Diagnostics
- Molecular Biology
- Parasitology
Background:
- Current schistosomiasis diagnosis methods, including microscopy for egg detection and immunological screening, have limitations such as low sensitivity and persistent positivity post-treatment.
- Molecular diagnostic approaches are emerging as superior alternatives to overcome the disadvantages of traditional methods.
Purpose of the Study:
- To explore the potential of the epigenome as a source of complementary data for genome knowledge in schistosomiasis diagnosis.
- To highlight the development of molecular methodologies based on epigenetic biomarkers for improved disease diagnosis and early clinical treatment.
Main Methods:
- Review of current laboratory diagnostic methods for schistosomiasis (microscopy, immunological screening).
- Focus on the development and application of molecular methodologies utilizing epigenetic biomarkers.
Main Results:
- Epigenetic biomarkers show potential for enhancing schistosomiasis diagnosis.
- Molecular methods based on epigenetics offer advantages over existing diagnostic techniques.
Conclusions:
- The epigenome provides valuable complementary data for schistosomiasis diagnosis.
- Epigenetic biomarker-based molecular diagnostics can lead to earlier detection and intervention, preventing severe liver damage.

